American Society of Echocardiography (ASE) Echo Hawaii™ 2026

American Society of Echocardiography (ASE) Echo Hawaii™ 2026 is organized by American Society of Echocardiography (ASE) and will be held from Jan 19 - 22, 2026 at Fairmont Orchid - Hawaii, Kohala Coast, Hawaii, United States of America.

Description:
Echo Hawaii^TM is one of ASE’s premier educational programs. Attendees receive in-depth, case-based learning on established and emerging cardiovascular ultrasound technologies in a beautiful and relaxed environment. Particular focus is placed on the application of advanced cardiovascular imaging technologies in the clinical setting. The program is structured to allow attendees to closely interact on a personal level with internationally recognized leaders in echocardiography, including special sessions on clinical dilemmas and technology-based workshops.

Program content includes state-of-the-art methods for evaluating ventricular systolic and diastolic function, valve function, pericardial disease, ischemic heart disease, critical care echo, cardiac POCUS and use of TEE. Content also includes cutting edge information on the assessment and guidance of cardiac devices, integration of echo in patients with cardiomyopathies, contrast ultrasound for cavity opacification and perfusion, strain echocardiography, and 3D imaging.

This event is co-sponsored by the Canadian Society of Echocardiography (CSE) and the Asian Pacific Association of Echocardiography (AAE).

Learning Objectives
Upon completion of this program, participants will be better able to:

• Integrate echocardiographic information in clinical decision making.
• Incorporate transesophageal echo to guide structural heart procedures.
• Assess ventricular and valvular function using advanced technologies and Doppler hemodynamics.
• Describe Doppler assessment of diastolic function/dysfunction.
• Explain new advances in the echocardiographic assessment of left and right ventricular function.
• Integrate echocardiographic assessment of cardiomyopathies and systemic diseases in patient management.
• Define clinical uses of TEE and 3D echocardiography.
• Recognize how echocardiography is used to help manage patients with ischemic heart disease.
• Recognize the role of echo contrast and be able to incorporate its use in the echo laboratory.
• Integrate echo information in the management of complex valvular heart disease.
• Explain the role of echocardiography in the perioperative and critical care environment.
• Explain how management for heart failure can be guided by echocardiography.
• Recognize emerging applications such as myocardial perfusion imaging, artificial intelligence, etc.
• Manage patients according to new guideline documents.
• Understand the role of echocardiography in aortic disease.